Medical Polymer Market - Global Industry Analysis

Medical Polymer Market by Product Type (Smart Polymers, Biodegradable, Bioabsorbable, and Others), by Application (Medical Devices and Equipment, Medical Packaging, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Published Date: 11-May-2021 Category: Chemical & Materials Report Format : PDF Pages: 125 Report Code: ZMR-4560 Status : Published

The global medical polymer market accounted for USD 14.88 Billion in 2020 and is expected to reach USD 27.25 Billion by 2028, growing at a CAGR of 7.9% from 2021 to 2028.

Description

Market Overview

The global medical polymer market accounted for USD 14.88 Billion in 2020 and is expected to reach USD 27.25 Billion by 2028, growing at a CAGR of 7.9% from 2021 to 2028.

Polymers are compounds that are usually of high molecular weight and are formed by combination of simpler molecules (monomers). Medical-grade polymers are an integral part of the global healthcare infrastructure and have been have been used in medical industry for decades. Polymers are used in a wide range of devices, from surgical instruments to implants and catheters. Metal substitution coupled with the growing awareness around maintaining proper health and hygiene are the driving factors for increasing demand for medical polymers, among others. Emergence of bioresorbables, use of polymers like PEEK and technological advancements in medical polymer industry are some of the trends witnessed by this industry in recent years.

COVID-19 Impact Analysis

The COVID-19 pandemic highlighted the role of polymers in modern times. If consumerism was once the driving force behind the use of polymers, personal wellbeing and medical crises have emerged as the driving forces in the aftermath of COVID. Due to the overwhelming demand for hospital resources, the healthcare industry witnessed a drop in medical-hospital materials and personal protective devices for health workers and the general population. This paved way to the emergence of alternative production movements focused on polymers.

Growth Factors

In the medical industry polymers are increasingly used as a substitute for their metallic counterpart. When it comes to equipment, cleanliness is a crucial aspect in the medical industry. Infection is the most serious danger that hospital patients face. Metal is more difficult to disinfect and sterilize than polymer and plastic materials. In addition to this, orthopedic OEMs can reach ergonomic weight limits for surgical trays by using polymers and plastic surgical materials. Use of metallic instrument only adds weight and strain to the surgical team carrying and using metal instruments.

The COVID-19 pandemic has paved way to the growing awareness around maintaining proper health and hygiene not only by the professionals in the medical field but also by general population. This has led to increase in the consumption of polymers for the manufacturing of masks, gloves, drapes, gowns, trays, catheters, syringes, orthopedic instruments, surgical equipment, and lab wares. Increased demand for personal protective equipment (PPE) such as gloves, caps, drapes, gowns, and other items fueled the demand for traditional plastics such as PP, PE, and PVC.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Product Type Segment Analysis Preview

The smart polymers segment held a share of around 5% in 2020. This share is attributed to the growing potential of smart polymers in developing novel drug delivery technologies. These smart polymers are designed to produce a pulsating drug release pattern for a variety of drug delivery applications, closely resembling natural biological release. The growing popularity of innovative drug delivery systems is boosting this segment’s growth. Developments in the chemistries of smart polymers are constantly revealing new opportunities in the smart polymers industry. A primary factor for new avenues in the smart polymers segment is the growing need for advanced packaging to maintain the freshness and sensory attributes of contents inside.

Application Segment Analysis Preview

The medical devices and equipment segment will grow at a CAGR of over 9% from 2021 to 2028. This is attributable to the increasing adoption of polymers in manufacturing of medical devices and equipment. Medical polymers have a number of advantages, including higher flexibility, comfort, and mobility. These polymers are best suited for medical applications because they are lighter, more biocompatible, and less expensive. PVC, preceded by PE, PET, PS, and PP, is the most commonly used plastic material in medical applications. PVC is a flexible plastic widely used in pre-sterilized single use medical application. Furthermore they are also used for packaging because of their lightness, low cost, durability, and transparency. As a result of the numerous advantages provided by medical polymers, their demand in the medical field is increasing and is thus accelerating the growth of the medical polymer industry.

Regional Analysis Preview

The European region held a share of around 20% in 2020. This is attributable to the aging population in the countries like Italy. Aging of population in this region has lead to an increased demand for medical polymers in hip and joint replacement applications, and spinal and cranial implants. These applications are gaining popularity and are expected to significantly impact the market growth.

Asia Pacific region is projected to grow at a CAGR of around 10% over the forecast period. This increase can be attributed to the fact that healthcare programs in countries like China, India, Bangladesh, Indonesia, and Pakistan are rapidly expanding, which will support the growth of this market in Asia Pacific region. The increased demand for medical polymers is also aided by the region's growing population coupled with the lack of adequate pharmacy facilities.

Key Market Players & Competitive Landscape

Some of key players in medical polymer market are SABI, BASF, Solvay, Celanese, Evonik, Covestro, DSM, DowDuPont, INEOS, and Victrex among others. Leading companies in the industry are focusing on strategies such as product diversification and geographic expansion in order to grow. Eastman Chemical Company recently extended its production facilities at various manufacturing locations in Middelburg in Netherlands and Jefferson in Pennsylvania. Furthermore, a majority of the market's big players have registered and copyrighted their inventions. This provides them with a strategic edge over the other industry competitors. For example, Bayer AG has registered the brand name Makrolon for its medical polymers, while DSM N.V. sells its medical polymers under the approved brand name Akulon, and Dow Chemical Company sells its trademark polymer products as DOW HEALTH+ polymers.

The global medical polymer market is segmented as follows:

By Product Type

  • Smart Polymers
  • Biodegradable
  • Bioabsorbable
  • Others

By Application

  • Medical Devices and Equipment
  • Medical Packaging
  • Others

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Product Type
        • 2.1.1.2. Market Attractiveness Analysis, By Application
        • 2.1.1.3. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Medical Pulymer Market, 2016 – 2028 (USD Million)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Medical Pulymer Market – Product Type Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Product Type, 2020 & 2028
    • 4.2. Smart Pulymers
      • 4.2.1. Market Size and Forecast, By Region (USD Million)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Biodegradable
      • 4.3.1. Market Size and Forecast, By Region (USD Million)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Bioabsorbable
      • 4.4.1. Market Size and Forecast, By Region (USD Million)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.5. Others
      • 4.5.1. Market Size and Forecast, By Region (USD Million)
      • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Medical Pulymer Market – Application Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Application, 2020 & 2028
    • 5.2. Medical Devices and Equipment
      • 5.2.1. Market Size and Forecast, By Region (USD Million)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Medical Packaging
      • 5.3.1. Market Size and Forecast, By Region (USD Million)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Others
      • 5.4.1. Market Size and Forecast, By Region (USD Million)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6 Medical Pulymer Market – Regional Analysis
    • 6.1. Overview
      • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 6.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
    • 6.2. North America
      • 6.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.2.2. North America Market Revenue, By Product Type, 2016 – 2028
      • 6.2.3. North America Market Revenue, By Application, 2016 – 2028
      • 6.2.4. U.S.
        • 6.2.4.1. U.S. Market Revenue, By Product Type, 2016 – 2028
        • 6.2.4.2. U.S. Market Revenue, By Application, 2016 – 2028
      • 6.2.5. Canada
        • 6.2.5.1. Canada Market Revenue, By Product Type, 2016 – 2028
        • 6.2.5.2. Canada Market Revenue, By Application, 2016 – 2028
      • 6.2.6. Mexico
        • 6.2.6.1. Mexico Market Revenue, By Product Type, 2016 – 2028
        • 6.2.6.2. Mexico Market Revenue, By Application, 2016 – 2028
    • 6.3. Europe
      • 6.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.3.2. Europe Market Revenue, By Product Type, 2016 – 2028
      • 6.3.3. Europe Market Revenue, By Application, 2016 – 2028
      • 6.3.4. Germany
        • 6.3.4.1. Germany Market Revenue, By Product Type, 2016 – 2028
        • 6.3.4.2. Germany Market Revenue, By Application, 2016 – 2028
      • 6.3.5. France
        • 6.3.5.1. France Market Revenue, By Product Type, 2016 – 2028
        • 6.3.5.2. France Market Revenue, By Application, 2016 – 2028
      • 6.3.6. U.K.
        • 6.3.6.1. U.K. Market Revenue, By Product Type, 2016 – 2028
        • 6.3.6.2. U.K. Market Revenue, By Application, 2016 – 2028
      • 6.3.7. Italy
        • 6.3.7.1. Italy Market Revenue, By Product Type, 2016 – 2028
        • 6.3.7.2. Italy Market Revenue, By Application, 2016 – 2028
      • 6.3.8. Spain
        • 6.3.8.1. Spain Market Revenue, By Product Type, 2016 – 2028
        • 6.3.8.2. Spain Market Revenue, By Application, 2016 – 2028
      • 6.3.9. Rest of Europe
        • 6.3.9.1. Rest of Europe Market Revenue, By Product Type, 2016 – 2028
        • 6.3.9.2. Rest of Europe Market Revenue, By Application, 2016 – 2028
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.4.2. Asia Pacific Market Revenue, By Product Type, 2016 – 2028
      • 6.4.3. Asia Pacific Market Revenue, By Application, 2016 – 2028
      • 6.4.4. China
        • 6.4.4.1. China Market Revenue, By Product Type, 2016 – 2028
        • 6.4.4.2. China Market Revenue, By Application, 2016 – 2028
      • 6.4.5. Japan
        • 6.4.5.1. Japan Market Revenue, By Product Type, 2016 – 2028
        • 6.4.5.2. Japan Market Revenue, By Application, 2016 – 2028
      • 6.4.6. India
        • 6.4.6.1. India Market Revenue, By Product Type, 2016 – 2028
        • 6.4.6.2. India Market Revenue, By Application, 2016 – 2028
      • 6.4.7. South Korea
        • 6.4.7.1. South Korea Market Revenue, By Product Type, 2016 – 2028
        • 6.4.7.2. South Korea Market Revenue, By Application, 2016 – 2028
      • 6.4.8. South-East Asia
        • 6.4.8.1. South-East Asia Market Revenue, By Product Type, 2016 – 2028
        • 6.4.8.2. South-East Asia Market Revenue, By Application, 2016 – 2028
      • 6.4.9. Rest of Asia Pacific
        • 6.4.9.1. Rest of Asia Pacific Market Revenue, By Product Type, 2016 – 2028
        • 6.4.9.2. Rest of Asia Pacific Market Revenue, By Application, 2016 – 2028
    • 6.5. Latin America
      • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.5.2. Latin America Market Revenue, By Product Type, 2016 – 2028
      • 6.5.3. Latin America Market Revenue, By Application, 2016 – 2028
      • 6.5.4. Brazil
        • 6.5.4.1. Brazil Market Revenue, By Product Type, 2016 – 2028
        • 6.5.4.2. Brazil Market Revenue, By Application, 2016 – 2028
      • 6.5.5. Argentina
        • 6.5.5.1. Argentina Market Revenue, By Product Type, 2016 – 2028
        • 6.5.5.2. Argentina Market Revenue, By Application, 2016 – 2028
      • 6.5.6. Rest of Latin America
        • 6.5.6.1. Rest of Latin America Market Revenue, By Product Type, 2016 – 2028
        • 6.5.6.2. Rest of Latin America Market Revenue, By Application, 2016 – 2028
    • 6.6. The Middle-East and Africa
      • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.6.2. The Middle-East and Africa Market Revenue, By Product Type, 2016 – 2028
      • 6.6.3. The Middle-East and Africa Market Revenue, By Application, 2016 – 2028
      • 6.6.4. GCC Countries
        • 6.6.4.1. GCC Countries Market Revenue, By Product Type, 2016 – 2028
        • 6.6.4.2. GCC Countries Market Revenue, By Application, 2016 – 2028
      • 6.6.5. South Africa
        • 6.6.5.1. South Africa Market Revenue, By Product Type, 2016 – 2028
        • 6.6.5.2. South Africa Market Revenue, By Application, 2016 – 2028
      • 6.6.6. Rest of Middle-East Africa
        • 6.6.6.1. Rest of Middle-East Africa Market Revenue, By Product Type, 2016 – 2028
        • 6.6.6.2. Rest of Middle-East Africa Market Revenue, By Application, 2016 – 2028
  • Chapter No. 7 Medical Pulymer Market – Industry Analysis
    • 7.1. Introduction
    • 7.2. Market Drivers
    • 7.3. Market Restraints
    • 7.4. Market Opportunities
    • 7.5. Porter’s Five Forces Analysis
    • 7.6. PEST Analysis
    • 7.7. Regulatory Landscape
    • 7.8. Technology Landscape
    • 7.9. Regional Market Trends
      • 7.9.1. North America
      • 7.9.2. Europe
      • 7.9.3. Asia Pacific
      • 7.9.4. Latin America
      • 7.9.5. The Middle-East and Africa
    • 7.10. Pricing Analysis
    • 7.11. Value Chain Analysis
    • 7.12. Downstream Buyers
    • 7.13. Distributors/Traders List
  • Chapter No. 8 Competitive Landscape
    • 8.1. Company Market Share Analysis – 2019
      • 8.1.1. Global Medical Pulymer Market: Company Market Share, 2019
      • 8.1.2. Global Medical Pulymer Market, Company Market Revenue, 2016 – 2019 (USD Million)
      • 8.1.3. Global Medical Pulymer Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 8.1.4. Global Medical Pulymer Market: Radar Determinant Chart, 2019
    • 8.2. Strategic Developments
      • 8.2.1. Acquisitions & Mergers
      • 8.2.2. New Product Launch
      • 8.2.3. Regional Expansion
    • 8.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 9 Company Profiles
    • 9.1. SABI
    • 9.2. BASF
    • 9.3. Sulvay
    • 9.4. Celanese
    • 9.5. Evonik
    • 9.6. Covestro
    • 9.7. DSM
    • 9.8. DowDuPont
    • 9.9. INEOS
    • 9.10. Victrex
  • Chapter No. 10 Marketing Strategy Analysis
    • 10.1. Marketing Channel
    • 10.2. Direct Marketing
    • 10.3. Indirect Marketing
    • 10.4. Marketing Channel Development Trends
    • 10.5. Economic/Pulitical Environmental Change
  • Chapter No. 11 Research Methodology
    • 11.1. Research Methodology
    • 11.2. Phase I - Secondary Research
    • 11.3. Phase II - Data Modeling
      • 11.3.1. Company Share Analysis Model
      • 11.3.2. Revenue Based Modeling
    • 11.4. Phase III - Primary Research
    • 11.5. Research Limitations
      • 11.5.1. Assumptions

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Product Type
FIG NO. 2. Market Attractiveness Analysis, By Application
FIG NO. 3. Market Attractiveness Analysis, By Region
FIG NO. 4. Global Medical Polymer Market Revenue, 2016 – 2028 (USD Million)
FIG NO. 5. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 6. Market Revenue Share, By Product Type, 2020 & 2028
FIG NO. 7. Global Medical Polymer Market for Smart Polymers, Revenue (USD Million) 2016 – 2028
FIG NO. 8. Comparative Revenue Analysis of Medical Polymer Market for Smart Polymers, By Country, 2020 & 2028
FIG NO. 9. Global Medical Polymer Market for Biodegradable, Revenue (USD Million) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Medical Polymer Market for Biodegradable, By Country, 2020 & 2028
FIG NO. 11. Global Medical Polymer Market for Bioabsorbable, Revenue (USD Million) 2016 – 2028
FIG NO. 12. Comparative Revenue Analysis of Medical Polymer Market for Bioabsorbable, By Country, 2020 & 2028
FIG NO. 13. Global Medical Polymer Market for Others, Revenue (USD Million) 2016 – 2028
FIG NO. 14. Comparative Revenue Analysis of Medical Polymer Market for Others, By Country, 2020 & 2028
FIG NO. 15. Market Revenue Share, By Application, 2020 & 2028
FIG NO. 16. Global Medical Polymer Market for Medical Devices and Equipment, Revenue (USD Million) 2016 – 2028
FIG NO. 17. Comparative Revenue Analysis of Medical Polymer Market for Medical Devices and Equipment, By Country, 2020 & 2028
FIG NO. 18. Global Medical Polymer Market for Medical Packaging, Revenue (USD Million) 2016 – 2028
FIG NO. 19. Comparative Revenue Analysis of Medical Polymer Market for Medical Packaging, By Country, 2020 & 2028
FIG NO. 20. Global Medical Polymer Market for Others, Revenue (USD Million) 2016 – 2028
FIG NO. 21. Comparative Revenue Analysis of Medical Polymer Market for Others, By Country, 2020 & 2028
FIG NO. 22. Global Medical Polymer Market Revenue Share, By Region, 2020 & 2028
FIG NO. 23. North America Medical Polymer Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 24. Porter’s Five Forces Analysis for Global Medical Polymer Market
FIG NO. 25. PEST Analysis for Global Medical Polymer Market
FIG NO. 26. Pricing Analysis for Global Medical Polymer Market
FIG NO. 27. Value Chain Analysis for Global Medical Polymer Market
FIG NO. 28. Company Share Analysis, 2019
FIG NO. 29. Radar Determinant Chart, 2019
FIG NO. 30. Company Strategic Developments – Heat Map Analysis
FIG NO. 31. SABI Business Segment Revenue Share, 2020 (%)
FIG NO. 32. SABI Geographical Segment Revenue Share, 2020 (%)
FIG NO. 33. Market Channels
FIG NO. 34. Marketing Channel Development Trend
FIG NO. 35. Growth in World Gross Product, 2008-2018
FIG NO. 36. Research Methodology – Detailed View
FIG NO. 37. Research Methodology
 


List of Tables 

TABLE NO. 1. Global Medical Polymer Market: Snapshot
TABLE NO. 2. Quarterly Medical Polymer Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Medical Polymer Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
TABLE NO. 6. Global Medical Polymer Market for Smart Polymers, by Region, 2016 – 2028 (USD Million)
TABLE NO. 7. Global Medical Polymer Market for Biodegradable, by Region, 2016 – 2028 (USD Million)
TABLE NO. 8. Global Medical Polymer Market for Bioabsorbable, by Region, 2016 – 2028 (USD Million)
TABLE NO. 9. Global Medical Polymer Market for Others, by Region, 2016 – 2028 (USD Million)
TABLE NO. 10. Global Medical Polymer Market for Medical Devices and Equipment, by Region, 2016 – 2028 (USD Million)
TABLE NO. 11. Global Medical Polymer Market for Medical Packaging, by Region, 2016 – 2028 (USD Million)
TABLE NO. 12. Global Medical Polymer Market for Others, by Region, 2016 – 2028 (USD Million)
TABLE NO. 13. Global Medical Polymer Market Revenue, By Region, 2016 – 2028 (USD Million)
TABLE NO. 14. North America Medical Polymer Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 15. North America Medical Polymer Market Revenue, By Product Type, 2016 – 2028 (USD Million)
TABLE NO. 16. North America Medical Polymer Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 17. U.S. Medical Polymer Market Revenue, By Product Type, 2016 – 2028 (USD Million)
TABLE NO. 18. U.S. Medical Polymer Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 19. Canada Medical Polymer Market Revenue, By Product Type, 2016 – 2028 (USD Million)
TABLE NO. 20. Canada Medical Polymer Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 21. Mexico Medical Polymer Market Revenue, By Product Type, 2016 – 2028 (USD Million)
TABLE NO. 22. Mexico Medical Polymer Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 23. Drivers for the Medical Polymer Market: Impact Analysis
TABLE NO. 24. Restraints for the Medical Polymer Market: Impact Analysis
TABLE NO. 25. Major Buyers of Medical Polymer
TABLE NO. 26. Distributors/Traders List of Medical Polymer
TABLE NO. 27. Global Medical Polymer Market, Company Market Revenue, 2016 – 2019 (USD Million)
TABLE NO. 28. Global Medical Polymer Market, Company Y-o-Y Growth, 2017 – 2019 (USD Million)


 

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The global medical polymer market was valued at USD 14.88 Billion in 2020.

The global medical polymer market is expected to reach USD 27.25 Billion by 2028, growing at a CAGR of 7.9% between 2021 to 2028.

Some of the key factors driving the global medical polymer market growth are the need for metal substitution coupled with the growing awareness around maintaining proper health and hygiene among others.

Asia Pacific region held a substantial share of the medical polymer market in 2020. This is attributable to the fact that healthcare programs in countries like China, India, Bangladesh, Indonesia, and Pakistan are rapidly expanding, which will support the growth of this market in Asia Pacific region. The growth is also aided by the region's growing population and the lack of adequate pharmacy facilities.

Some of the major companies operating in the global medical polymer market are SABI, BASF, Solvay, Celanese, Evonik, Covestro, DSM, DowDuPont, INEOS, and Victrex, among others.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed